| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.50B | 3.36B | 3.17B | 2.83B | 2.96B | 2.19B |
| Gross Profit | 1.89B | 1.80B | 1.70B | 1.38B | 1.55B | 1.09B |
| EBITDA | 731.58M | 719.12M | 696.64M | 464.09M | 627.01M | 295.21M |
| Net Income | 478.00M | 408.00M | 404.10M | 220.46M | 360.82M | 107.76M |
Balance Sheet | ||||||
| Total Assets | 4.40B | 4.07B | 3.95B | 3.54B | 3.66B | 3.67B |
| Cash, Cash Equivalents and Short-Term Investments | 595.26M | 816.83M | 697.69M | 447.72M | 638.00M | 746.71M |
| Total Debt | 768.60M | 924.22M | 852.20M | 788.19M | 833.09M | 1.03B |
| Total Liabilities | 1.33B | 1.35B | 1.31B | 1.21B | 1.30B | 1.41B |
| Stockholders Equity | 2.99B | 2.72B | 2.63B | 2.32B | 2.35B | 2.25B |
Cash Flow | ||||||
| Free Cash Flow | 487.63M | 379.37M | 416.04M | 53.36M | 369.27M | 303.87M |
| Operating Cash Flow | 579.73M | 521.19M | 575.76M | 238.72M | 510.72M | 376.32M |
| Investing Cash Flow | -298.13M | -145.47M | -154.96M | -227.55M | -142.65M | -47.32M |
| Financing Cash Flow | -398.21M | -227.70M | -173.64M | -201.79M | -452.12M | -32.95M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$4.93B | 10.39 | 17.42% | 3.65% | 6.87% | 18.37% | |
74 Outperform | HK$1.90B | 12.32 | 3.76% | 7.46% | 21.39% | -0.57% | |
72 Outperform | HK$26.13B | 45.22 | 24.57% | 0.63% | 13.58% | 24.59% | |
70 Neutral | HK$5.46B | 26.37 | 10.31% | ― | 14.06% | 3.02% | |
56 Neutral | HK$11.41B | ― | ― | ― | ― | ― | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
Modern Dental Group Limited announced the retirement of Dr. Cheung Wai Man William as an independent non-executive director, effective December 15, 2025, as he intends to focus on other commitments. Following his departure, Dr. Yau Ka Po will assume the roles of chairman of the remuneration committee and member of the nomination committee, indicating a strategic shift in the company’s board composition.
The most recent analyst rating on (HK:3600) stock is a Buy with a HK$4.50 price target. To see the full list of analyst forecasts on Modern Dental Group Limited stock, see the HK:3600 Stock Forecast page.
Modern Dental Group Limited has announced an updated list of its board of directors, effective from December 15, 2025. The board comprises executive directors including Dr. Ronald Yik Long Chan as Chairman and CEO, and Ms. Yik Yu Chan as Chief Marketing Officer, among others. The company also has non-executive and independent non-executive directors. The board oversees three committees: Audit, Nomination, and Remuneration, each chaired by different members. This announcement reflects the company’s commitment to structured governance and strategic leadership, which may influence its operational efficiency and stakeholder confidence.
The most recent analyst rating on (HK:3600) stock is a Buy with a HK$4.50 price target. To see the full list of analyst forecasts on Modern Dental Group Limited stock, see the HK:3600 Stock Forecast page.
Modern Dental Group Limited announced a change in the shareholding structure of its controlling shareholder, Triera Holdings Limited. On December 5, 2025, Mr. Chan Kwun Fung transferred 50% of Triera’s issued share capital to CKF Family Limited as part of family planning and succession arrangements. Despite the transfer, Mr. Chan Kwun Fung and Mr. Chan Kwun Pan continue to act in concert regarding the company’s shares. The transfer triggered an obligation for a mandatory general offer under the Takeovers Code, but a waiver was granted by the Securities and Futures Commission.
The most recent analyst rating on (HK:3600) stock is a Buy with a HK$4.50 price target. To see the full list of analyst forecasts on Modern Dental Group Limited stock, see the HK:3600 Stock Forecast page.
Modern Dental Group Limited announced the grant of 23,250,000 share options to its directors and employees as part of its share option scheme. This initiative is aimed at recognizing the past performance and contributions of the grantees, as well as their potential future contributions to the company, thereby aligning their interests with the company’s long-term growth objectives.
The most recent analyst rating on (HK:3600) stock is a Buy with a HK$4.50 price target. To see the full list of analyst forecasts on Modern Dental Group Limited stock, see the HK:3600 Stock Forecast page.
Modern Dental Group Limited reported a record revenue increase of approximately 9.2% for the nine months ending September 30, 2025, despite a challenging macro-economic environment. The company’s strategic focus on digital transformation and operational efficiency has allowed it to outperform industry peers and capitalize on emerging opportunities, particularly in Europe and through acquisitions like Hexa Ceram.
The most recent analyst rating on (HK:3600) stock is a Buy with a HK$4.50 price target. To see the full list of analyst forecasts on Modern Dental Group Limited stock, see the HK:3600 Stock Forecast page.